High-strength tretinoin for rapid retinization of photoaged facial skin

Dermatol Surg. 2004 Jun;30(6):864-6. doi: 10.1111/j.1524-4725.2004.30254.x.

Abstract

Background: Emollient creams of 0.02% and 0.05% tretinoin are currently used for improving the appearance of photoaged skin. At these concentrations, using this vehicle, the clinical results take many months.

Objective: The objective was to formulate and test a higher strength tretinoin that enhances penetration of the active molecule through the stratum corneum so that the clinical result is achieved after 1 month of treatment.

Methods: Thirty-two female subjects underwent treatment with 0.25% tretinoin solution applied nightly for 1 month. Subjects were evaluated clinically at baseline and 1, 2, and 4 weeks. Clinical grading was performed by comparing digital photographs before and after treatment.

Results: Almost all subjects improved on all measures of clinical grading (fine lines, mottled pigmentation, surface texture/roughness) by the end of the study.

Conclusion: Tretinoin solution at a concentration of 0.25% is an effective and tolerable treatment for photodamaged facial skin and greatly shortens the time required for clinical response.

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Drug Administration Schedule
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / pathology
  • Female
  • Humans
  • Keratolytic Agents / administration & dosage
  • Keratolytic Agents / therapeutic use*
  • Middle Aged
  • Skin Aging / pathology*
  • Treatment Outcome
  • Tretinoin / administration & dosage
  • Tretinoin / therapeutic use*

Substances

  • Keratolytic Agents
  • Tretinoin